The global tacrolimus injection market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Tacrolimus, also known as Prograf, is an immunosuppressive drug primarily used with other medications to prevent rejection of a heart, kidney, or liver transplant in adult and pediatric patients. This medication works by supporting the body to accept the new organ and lower the risk of organ rejection so as to prevent the body from attacking and rejecting the transplanted organ which could be liver, kidney, or even heart. The growth of the market is attributed to the rising number of organ transplant among adult and pediatric patients globally.
A full report of Global Tacrolimus Injection Market is available at:https://orionmarketreports.com/global-tacrolimus-injection-market/93909/
Prograf is an instance of tacrolimus injection is which is available as a sterile solution (tacrolimus injection) that contains the equivalent of 5 mg anhydrous tacrolimus in 1 mL for administration by intravenous infusion only. Each ml consists of polyoxyl 60 hydrogenated castor oil (HCO-60), 200 mg, and dehydrated alcohol, USP, 80.0% v/v. Prograf injection must be diluted with 0.9% Sodium Chloride Injection or 5% Dextrose Injection before use. Tacrolimus, previously known as FK506, is the active ingredient in Prograf. Tacrolimus is a macrolide immunosuppressant produced by Streptomyces tsukubaensis. The recommended starting dose of Prograf injection is 0.03-0.05 mg/kg/day in kidney and liver transplant and 0.01 mg/kg/day in heart transplant given as a continuous IV infusion.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Application
- Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape: Pfizer Inc., and Astellas Pharma Inc., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Tacrolimus Injection Market Report by Segment
By Application
- Kidney or Liver Transplant
- Heart Transplant
- Lung Transplant
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
